✦ LIBER ✦

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

✍ Scribed by Greenfield, J. R; Farooqi, I S.; Keogh, J. M; Henning, E.; Habib, A. M; Blackwood, A.; Reimann, F.; Holst, J. J; Gribble, F. M

Book ID: 127287501
Publisher: American Society for Clinical Nutrition:
Year: 2008
Tongue: English
Weight: 318 KB
Volume: 89
Category: Article
ISSN: 0002-9165
DOI: 10.3945/ajcn.2008.26362

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Similar Elimination Rates of Glucagon-Li

✍ Vilsbøll, T.; Agersø, H.; Krarup, T.; Holst, J. J. 📂 Article 📅 2003 🏛 Endocrine Society 🌐 English ⚖ 112 KB

Racial differences in glucagon-like pept

Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects

✍ Velasquez-Mieyer, P A; Cowan, P A; Umpierrez, G E; Lustig, R H; Cashion, A K; Bu 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Addition of metformin to exogenous gluca

Addition of metformin to exogenous glucagon-like peptide–1 results in increased serum glucagon-like peptide–1 concentrations and greater glucose lowering in type 2 diabetes mellitus

✍ Joy Cuthbertson; Steven Patterson; Finbarr P. O'Harte; Patrick M. Bell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Impaired cardiometabolic responses to gl

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

✍ Moberly, Steven P.; Mather, Kieren J.; Berwick, Zachary C.; Owen, Meredith K.; G 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 619 KB

Plasma glucagon and glucagon-like immuno

Plasma glucagon and glucagon-like immunoreactive components in Type 1 (insulin-dependent) diabetic patients and normal subjects before and after an oral glucose load

✍ A. Rovira; F. J. Garrote; J. M. Pascual; M. G. Salvador; J. L. Herrera Pombo; I. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 723 KB

Biogel P-30 filtration of plasma from Type 1 (insulin-dependent) diabetic patients and normal subjects in basal state and after an oral glucose load was assayed with a C-terminal (30 K) and a glucagon-like immunoreactivity-cross-reacting antiserum (R8). Up to four immunoreactive peaks of approximate

Effects of short-term intensive glycemic

Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes

✍ M. Shimodaira MD, PhD,Y. Muroya,N. Kumagai… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 131 KB